Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026)
Ardelyx's (ARDX) quarterly Other Working Capital Changes came in at -$571000.0 in Q1 2026, up 42.38% YoY from -$401035.4 in Q1 2025, and up 76.59% on a QoQ basis from -$2.4 million in Q4 2025.
Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 7 years of Other Working Capital Changes data on file, last reported at -$571000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 42.38% year-over-year to -$571000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (up 19.03% YoY) and the FY2025 annual result came in at -$3.9 million, up 14.71% from the prior year.
- Other Working Capital Changes grew to -$571000.0 in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.4 million in Q1 2024 to a low of -$1.8 million in Q2 2023.
- A 5-year average of $1.3 million and a median of $673000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 497.07% — and 2024, when it tumbled 321.27%.
- Tracing ARDX's Other Working Capital Changes over 5 years: stood at $3.3 million in 2022, then sank by 175.09% to -$2.4 million in 2023, then soared by 50.92% to -$1.2 million in 2024, then tumbled by 103.25% to -$2.4 million in 2025, then jumped by 76.59% to -$571000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$571000.0 (Q1 2026), -$2.4 million (Q4 2025), and -$206000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.47 Mn |
| Jun 30, 2026 | -4.47 Mn |
| Jun 30, 2026 | -4.47 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 327,000.00 |
| Dec 31, 2024 | 327,000.00 |